Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

985 testo del articulo about chlorhexidine, Study Guides, Projects, Research of Health sciences

Use of chlorhexidine in wound healing and granulation tissue formation

Typology: Study Guides, Projects, Research

2024/2025

Uploaded on 05/06/2025

reynee-shaira-matulac-borromeo
reynee-shaira-matulac-borromeo 🇵🇭

6 documents

1 / 8

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
139
AbstrAct
Introduction: Wounds with dressing defects pose a great challenge when choosing a good treatment that may reduce the risk
of infection and promote granulation tissue formation. Objective: To demonstrate the usefulness of chlorhexidine digluconate
(CHG) for granulation tissue formation. Materials and methods: Eighteen wounds (16 patients) that met the inclusion criteria
were included. Wound cleansing was performed in outpatients with 20% CHG-impregnated cloths every 48-72h, until the proper
tissue granulation was achieved. Photographs of the clinical evolution of the wounds were taken. results: The adequate wound
granulation mean was of 9.2days (4-25days) regardless of wound size or presence of comorbidities. There were no clinical signs
of infection in any wound during the healing period. conclusions: CHG treatment is an appropriate method to be considered for
outpatient injuries, which reduces the hospital costs borne by the health-care system.
Level of Evidence: III.
Key words: chlorhexidine, wounds, granulation tissue, skin dressing defect.
Uso del gluconato de clorhexidina en la curación de heridas y su potencial formación de tejido
de granulación
rEsUMEn
Introducción: Las heridas con defectos de coberturas suponen un gran desafío a la hora de elegir un buen tratamiento que
reduzca el riesgo de infección e incremente la capacidad de granulación del tejido. El objetivo de este estudio fue demostrar la
utilidad del digluconato de clorhexidina para la granulación de tejidos. Materiales y Métodos: Se incluyeron 18 heridas de 16
pacientes que cumplían con los criterios de inclusión. Se realizaron curaciones ambulatorias con gasas embebidas en digluconato
de clorhexidina al 20%, cada 48-72 h, hasta lograr la adecuada granulación de tejido y se tomaron fotografías de la evolución
clínica de las heridas. resultados: Se observó una adecuada granulación de las heridas en una media de 9.2 días (rango 4-25
días), independientemente del tamaño o de la comorbilidades. Ninguna herida presentó signos clínicos de infección durante el
período de curación. conclusiones: El uso de digluconato de clorhexidina es un adecuado método por tener en cuenta para tratar
heridas, de forma ambulatoria, y así disminuir los costos hospitalarios del sistema de salud.
Palabras claves: Clorhexidina; heridas; tejido de granulación; defecto de cobertura.
nivel de Evidencia: IV
IntroductIon
The antiseptic properties of CHG have been known since the 1950s.1 CHG common applications include from
oral hygiene to preoperative surgical preparation and the prevention of hospital-acquired infections due to multi-
drug-resistant organisms.1,2 CHG is a bisbiguanide and exists as a cationic form at physiological pH that binds to
the negatively charged bacterial cell wall, altering the osmotic equilibrium of the bacterial cell and resulting in the
leakage of cytoplasmic contents.3,4 CHG is water-insoluble, thus the commercial CHG for clinical applications is
usually formulated with gluconic acid to form water-soluble salts.3,4
Use of chlorhexidine in wound healing
and granulation tissue formation
Edgar G. Wagner, Juan M. sala
Orthopedics Department, Hospital Regional de Comodoro Rivadavia, Chubut, Argentina
InVEstIGAcIÓn cLÍnIcA
Esta Revista está bajo una Licencia Creative Commons Atribución-NoComercial-Compartir
Obras Derivadas Igual 4.0 Internacional. (CC-BY-NC-SA 4.0).
Rev Asoc Argent Ortop Traumatol 2020; 85 (2): 139-146 • ISSN 1852-7434 (online)
Received on April 21st, 2019. Accepted after evaluation on November 30th, 2019 Edgar G. Wagner, MD edgar.gw@hotmail.com https://orcid.org/0000-0001-9472-0014
How to cite this paper:
Wagner EG, Sala JM. Use of chlorhexidine in wound healing and granulation tissue formation. Rev Asoc Argent Ortop Traumatol 2020;85(2):139-146. https://doi.
org/10.15417/issn.1852-7434.2020.85.2.985
ID
pf3
pf4
pf5
pf8

Partial preview of the text

Download 985 testo del articulo about chlorhexidine and more Study Guides, Projects, Research Health sciences in PDF only on Docsity!

139

AbstrAct Introduction: Wounds with dressing defects pose a great challenge when choosing a good treatment that may reduce the risk of infection and promote granulation tissue formation. Objective: To demonstrate the usefulness of chlorhexidine digluconate (CHG) for granulation tissue formation. Materials and methods: Eighteen wounds (16 patients) that met the inclusion criteria were included. Wound cleansing was performed in outpatients with 20% CHG-impregnated cloths every 48-72 h, until the proper tissue granulation was achieved. Photographs of the clinical evolution of the wounds were taken. results: The adequate wound granulation mean was of 9.2 days (4-25 days) regardless of wound size or presence of comorbidities. There were no clinical signs of infection in any wound during the healing period. conclusions: CHG treatment is an appropriate method to be considered for outpatient injuries, which reduces the hospital costs borne by the health-care system. Level of Evidence: III. Key words: chlorhexidine, wounds, granulation tissue, skin dressing defect.

Uso del gluconato de clorhexidina en la curación de heridas y su potencial formación de tejido de granulación

rEsUMEn Introducción: Las heridas con defectos de coberturas suponen un gran desafío a la hora de elegir un buen tratamiento que reduzca el riesgo de infección e incremente la capacidad de granulación del tejido. El objetivo de este estudio fue demostrar la utilidad del digluconato de clorhexidina para la granulación de tejidos. Materiales y Métodos: Se incluyeron 18 heridas de 16 pacientes que cumplían con los criterios de inclusión. Se realizaron curaciones ambulatorias con gasas embebidas en digluconato de clorhexidina al 20%, cada 48-72 h, hasta lograr la adecuada granulación de tejido y se tomaron fotografías de la evolución clínica de las heridas. resultados: Se observó una adecuada granulación de las heridas en una media de 9.2 días (rango 4- días), independientemente del tamaño o de la comorbilidades. Ninguna herida presentó signos clínicos de infección durante el período de curación. conclusiones: El uso de digluconato de clorhexidina es un adecuado método por tener en cuenta para tratar heridas, de forma ambulatoria, y así disminuir los costos hospitalarios del sistema de salud. Palabras claves: Clorhexidina; heridas; tejido de granulación; defecto de cobertura. nivel de Evidencia: IV

IntroductIon

The antiseptic properties of CHG have been known since the 1950s.^1 CHG common applications include from

oral hygiene to preoperative surgical preparation and the prevention of hospital-acquired infections due to multi-

drug-resistant organisms. 1,2^ CHG is a bisbiguanide and exists as a cationic form at physiological pH that binds to

the negatively charged bacterial cell wall, altering the osmotic equilibrium of the bacterial cell and resulting in the

leakage of cytoplasmic contents. 3,4^ CHG is water-insoluble, thus the commercial CHG for clinical applications is

usually formulated with gluconic acid to form water-soluble salts.3,

Use of chlorhexidine in wound healing

and granulation tissue formation

Edgar G. Wagner, Juan M. sala Orthopedics Department, Hospital Regional de Comodoro Rivadavia, Chubut, Argentina

InVEstIGAcIÓn cLÍnIcA

Esta Revista está bajo una Licencia Creative Commons Atribución-NoComercial-CompartirObras Derivadas Igual 4.0 Internacional. (CC-BY-NC-SA 4.0). Rev Asoc Argent Ortop Traumatol 2020; 85 (2): 139-146 • ISSN 1852-7434 (online)

Received on April 21st, 2019. Accepted after evaluation on November 30th^ , 2019 • Edgar G. Wagner, MD • edgar.gw@hotmail.com ‘https://orcid.org/0000-0001-9472- How to cite this paper: Wagner EG, Sala JM. Use of chlorhexidine in wound healing and granulation tissue formation. Rev Asoc Argent Ortop Traumatol 2020;85(2):139-146. https://doi. org/10.15417/issn.1852-7434.2020.85.2.

ID

E. G. Wagner and J. M. sala

CHG has broad-spectrum activity and is highly effective against a wide variety of Gram-positive microorgan-

isms, such as Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus [MRSA]) and coagu-

lase negative Staphylococcus. It also demonstrates activity against Gram-negative bacteria, fungi and, to a lesser

extent, mycobacteria. It is sporostatic, but not sporicidal. 3,4^ It has a rapid onset, approximately 20 seconds, and a

prolonged residual effect. 2 The antimicrobial activity of CHG has been documented to persist up to 48 hours of

contact with skin. 4 It is bacteriostatic at low concentrations (0.0002% to 0.5%) and bactericidal at higher concen-

trations (>0.5%).3,

One of its most significant characteristics is its in vitro activity against enveloped viruses, including herpes sim-

plex virus, HIV, cytomegalovirus, influenza virus, and respiratory syncytial virus); however, it has lower activity

against non-enveloped viruses. 3

The beneficial effect of CHG on the granulation tissue formation in wound areas has been proven by some stud-

ies, mainly animal model studies (rabbits and pigs).^5

Our Department of Orthopedics has a non-systematized positive record concerning skin dressing defects in pa-

tients treated with 20% CHG-impregnated cloths.

The aim of this study is to demonstrate the usefulness of CHG in healing wounds (infected and non-infected)

and generating granulation tissue that would allow for an epithelialization procedure, a skin flap or graft or a refer-

ral to a plastic surgery specialist. To the best of our knowledge, there are no local or international studies on this

particular subject.

MaterIals and Methods

This is an observational retrospective study on all adult and pediatric patients of both sexes that were admitted

to our department between 1/7/2017 and 21/12/2018 due to skin dressing defects.

All wound dressing changes were performed by the author of this study. The inclusion criteria were: all patients

of both sexes who had skin dressing defects of different origins (e. g., surgical wound infection sequelae or wound

dehiscence) as well as different trauma injuries that precluded wound dressing. The exclusion criteria were: all

patients of both sexes who had epidermal wounds without dermal involvement and had achieved primary wound

closure or were on a treatment to promote wound epithelialization, and patients who had soft-tissue lesions due

to high-energy trauma or lacerated injuries, and had achieved primary wound closure. The study variables (Table

1) were: Demographic variables (sex) and Clinical variables (comorbidities, type and mechanism of injury, injury

size, wound healing time).

For all patients admitted into the examination room for wound dressing changes, the physician follows the fol-

lowing procedural steps:

1. Patients’ personal details are recorded and the consultation is entered into the medical record.

2. A wound picture is taken to document its evolution.

3. Wound cleansing is performed with abundant normal saline and 20% CHG soap (Laclorhex, 4g chlorhexidine

digluconate 20% solution, Laboratorio Sertex S.R.L, Rosario, Santa Fe, Argentina) (Figure 1).

4. Dressing composed of 20% CHG-impregnated cloths is placed.

5. Bandaging is applied

The wound dressing changes were performed with CHG-impregnated cloths (20%) every 48-72h until the

amount of granulation tissue detected allowed for a skin flap or graft procedure, a secondary wound closure using

vaseline or silver sulfadiazine cream or a referral to a plastic surgery specialist.

The wound dressing changes included the same procedural steps taken at the first consultation plus wound toilet

using a scalpel to remove fibrin from the wound before applying the 20% CHG-impregnated cloths (Figures 2-4).

The protocol of the study was approved by the Education, Training and Research Committee and the Bioethics

Committee of our Center.

E. G. Wagner and J. M. sala

A

Figure 1. 20% chlorhexidine digluconate soap used in this studt (Laclorhex, 4g chlorhexidine digluconate 20% solution, Laboratorio Sertex S.R.L, Rosario, Santa Fe, Argentina).

Figure 2. Traumatic amputation wound. a. Foot wound due to a motor vehicle accident with hallux amputation. B. Day 9 after 20% chlorhexidine digluconate treatment, case eligible for an epithelialization procedure, a skin flap or graft or a referral to a plastic surgery specialist.

A

b

Use of chlorhexidine in wound healing and granulation tissue formation

Figure 3. Morel-Lavallée injury. a. Postoperative Escharotomy, beginning of the chlorhexidine wound dressing change treatment. B. Day 8 after chlorhexidine digluconate treatment, case eligible for an epithelialization procedure, a skin flap or graft or a referral to a plastic surgery specialist.

Figure 4. Hand wound due to a crushing injury in a bakery bread-making machine. a. Day 1 after Escharotomy, beginning of the wound dressing change treatment. B. Day 6 after chlorhexidine digluconate treatment, case eligible for an epithelialization procedure, a skin flap or graft or a referral to a plastic surgery specialist.

A

A b

b

Use of chlorhexidine in wound healing and granulation tissue formation

of time. CHG enables wound dressing changes to be an outpatient procedure, with patients attending dressing

change appointments every 48-72h. This scheme significantly decreases hospitalization costs and, consequently,

the health-related expenses of the public health system.

Lee et al. conducted a cost-benefit study on preoperative skin antisepsis and found that switching from povidone-

iodine to chlorhexidine gluconate resulted in a net cost savings of 16-26 USD per surgical case and 349,904-

568,594 USD per year for the hospital. Additionally, although chlorhexidine gluconate is more expensive than

povidone-iodine, by decreasing the incidence of catheter-associated bloodstream infection, pneumonia, and super-

ficial and deep infections, it decreases the total costs. 12

conclusIon

Using 20% CHG as described herein constitutes an excellent treatment option for wounds with skin dressing

defects (infected and non-infected) which promotes granulation tissue formation, decreases hospitalization costs

of the public health system and reduces the probability of suffering wound infections. All the aforementioned

provide the rationale supporting CHG use in wounds with skin dressing defects that had failed to be adequately

treated with primary wound closure.

ORCID de J. M. Salas: https://orcid.org/0000-0002-8942-

reFerences

  1. Rhee Y, Palmer LJ, Okamoto K, Gemunden S, Hammouda K, Kemble SK, et al. Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery. Infect Control Hosp Epidemiol 2018;1-7. https://doi.org/10.1017/ice.2017.312.
  2. Wang EW, Layon AJ. Chlorhexidine gluconate use to prevent hospital-acquired infections - a useful tool, not a panacea. Ann Transl Med 2017;5(1):14. https://doi.org/10.21037/atm.2017.01.
  3. Maya JJ, Ruiz SJ, Pacheco R, Valderrama SL,Villegas MV. Papel de la clorhexidina en la prevención de las infecciones asociadas a la atención en salud. Infectio 2011;15(2):98-107. http://www.revistainfectio.org/index.php/infectio/article/view/12/
  4. George J, Klika AK, Higuera CA. Use of chlorhexidine preparations in total joint arthroplasty. J Bone Jt Infect 2017;2(1):15-22. https://doi.org/10.7150/jbji.16934.
  5. Archer HG, Barnett S, Irving S, Middletont KR, Seal DV. A controlled model of moist wound healing: comparison between semi-permeable film, antiseptics and sugar paste. J Exp Pathol (Oxford) 1990;71:155-70. PMID:
  6. Makhni MC, Jegede K, Lombardi J, Whittier S, Gorroochurn P, Lehman RA, et al. No clear benefit of chlorhexidine use at home before surgical preparation. J Am Acad Orthop Surg 2018;26:e39-e47. https://doi.org/10.5435/JAAOS-D-16-
  7. Edmiston CE Jr, Leaper D. Should preoperative showering or cleansing with chlorhexidine gluconate (CHG) be part of the surgical care bundle to prevent surgical site infection? J Infect Prev 2017;18(6):311-4. https://doi.org/10.1177/
  8. Phillips PL, Young D, Chakravarthy D. The compatibility of chlorhexidine and a skin care product line. A real-world analysis of hospital-acquired infection rates. Health Care Manag (Frederick) 2017;36(3):288-92. https://doi.org/10.1097/HCM.
  9. Hamill MB, Osato MS, Wilhelmus KR. Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother 1984;26(6):793-6. https://doi.org/10.1128/aac.26.6.

–––––––––––––––––– Conflict of interests: Authors claim they do not have any conflict of interests.

E. G. Wagner and J. M. sala

  1. Platt J, Bucknall RA. An experimental evaluation of antiseptic wound irrigation. J Hosp Infect 1984;5(2):181-8. https://doi.org/10.1016/0195-6701(84)90122-
  2. Winter GD, Scales JT. Effect of air drying and dressings in the surface of a wound. Nature 1963;197:91-2. https://doi.org/10.1038/197091b
  3. Lee I, Agarwal RK, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 2010;31(12):1219-29. https://doi.org/10.1086/657134.